354 Results (Page 14 of 15)
Kenya Markets Research Reports
Kenya PET Scan Market Analysis
The Kenya PET Scan Market was valued at $1.4 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $2.1 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Kenya PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Kenya Genomic Diagnostics Market Analysis
Kenya Genomic Diagnostics Market was valued at $22.86 Mn in 2023 and is predicted to grow at a CAGR of 17.6% from 2023 to 2030, to $71.09 Mn by 2030. The key drivers of this industry include technological advancements, growing demand for genetic services, and government support and funding. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Kenya Mouth Ulcer Therapeutics Market Analysis
The Kenya Mouth Ulcer Therapeutics Market was valued at $1.1 Mn in 2023 and is projected to grow at a CAGR of 5.0% from 2023 to 2023, to $1.5 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Dawa Life Sciences, Bayer, Beta Healthcare International, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Pfizer among others.
Kenya Exosome Research Market Analysis
The Kenya Exosome Research Market was valued at $0.1 Mn in 2023 and is projected to grow at a CAGR of 17.1% from 2023 to 2023, to $0.4 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as Hologic Inc., Luminex Corporation, Agilent Technologies, Inc., QIAGEN, FUJIFILM Irvine Scientific, Cusabio Technology Llc, Nexosome-Oncology, Norgen Biotek Corp., Miltenyi Biotec, Beckman Coulter, Inc., and Hitachi, Ltd., among others.
Kenya Bariatric Surgery Devices Market Analysis
The Kenya Bariatric Surgery Devices Marketwas valued at $1.9 Mn in 2023 and is projected to grow at a CAGR of 6.3% from 2023 to 2023, to $2.9 Mn by 2030. The market for bariatric surgical devices is being driven primarily by increased adult obesity rates, which are a result of changing lifestyles and consuming excessive amounts of calories. Over the course of the projection period, it is also expected that the demand for bariatric operations will increase as a result of growing public awareness of the harmful food and beverage options available in the market and how they affect body mass index (BMI), which will fuel the expansion of the bariatric surgery devices market. The prominent players in the market are Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
Kenya CT Scan Market Analysis
Kenya CT Scan Market was valued at $3.23 Mn in 2023 and is predicted to grow at a CAGR of 8.97% from 2023 to 2030, to $5.89 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, technological advancements, growing need for early diagnosis. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Koninklijke Philips, among others.
Kenya Lipid Disorder Therapeutics Market Analysis
Kenya Lipid Disorder Therapeutics Market was valued at $7.1 Mn in 2023 and is predicted to grow at a CAGR of 13.73% from 2023 to 2030, to $17.4 Mn by 2030. Kenya Lipid Disorder Therapeutics Market is growing due to Increasing Healthcare Expenditure, the Rising Prevalence of Cardiovascular Diseases (CVDs), Public Awareness, and Early Intervention. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Kenya Actinic Keratosis Therapeutic Market Analysis
Kenya Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 6% from $5 Mn in 2022 to $8 Mn by 2030. The market is expected to grow as a result of rising prevalence combined with specific environmental variables, a shifting economic landscape, rising disposable incomes, and more access to healthcare services in Kenya. International and local players Galderma, Bayer, Novartis, Mediheal Pharmaceuticals, Mifa, Kepharth etc, contribute to the therapeutic management of Actinic Keratosis
Kenya Mental Health Apps Market Analysis
The Kenya Mental Health Apps Market was valued at $4.34 Mn in 2023 and is predicted to grow at a CAGR of 16.3% from 2023 to 2030, to $12.49 Mn by 2030. The key drivers of this industry include government support, rising awareness, and increasing smartphone penetration. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Wazi among others.
Kenya Constipation Therapeutics Market Analysis
Kenya Constipation Therapeutics Market was valued at $13 Mn in 2022 and is estimated to reach $23 Mn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The constipation therapeutics market is experiencing worldwide expansion due to factors like aging, sedentary lifestyles, and poor dietary habits. The growing elderly demographic, prone to chronic conditions, plays a significant role in driving this growth. Key players in this industry include Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
Kenya Bio-Implant Market Analysis
The Kenya Bio-implant Market was valued at $45.5 Mn in 2023 and is predicted to grow at a CAGR of 7.0% from 2023 to 2030, to $73.1 Mn by 2030. The Kenya Bio-implant Market is growing due to Increasing Chronic Disease Prevalence, Improving Healthcare Infrastructure, and Urbanization. The market is primarily dominated by players such as Orthopedics and Pharmaceuticals Eldoret, Zwadi Healthcare Limited, Mac Naugton Limited, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Kenya Herbal Supplements Market Report
The Kenya Herbal Supplements Market was valued at $3.68 Mn in 2023 and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to $6.03 Mn by 2030. The key drivers of this industry include rising chronic disease, consumer preference for natural products, and increasing health consciousness. The industry is primarily dominated by players such as Himalaya Wellness, Patanjali Ayurved, Dabur, and NOW Foods among others.
Kenya Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Kenya Clinical Nutrition for Chronic Kidney Diseases Market was valued at $1.10 Mn in 2023 and is predicted to grow at a CAGR of 7.13% from 2023 to 2030, to $1.80 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness and diagnosis, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Kenya Brugada Syndrome Market Analysis
The Kenya Brugada Syndrome Market was valued at $0.8 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $1.5 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and increasing healthcare expenditure. The prominent players of the Kenya Brugada Syndrome Market are Siemens Healthcare, Aventis Pasteur, Eli-Lilly, Regal Pharmaceuticals, GSK Nairobi, and Novartis Rhone Poulenic, among others.
Kenya Blood Disorder Therapeutics Market
Kenya Blood Disorder Therapeutics Market valued at $9 Mn in 2022, projected to reach $18 Mn by 2030 with a 8.6% CAGR. The market in Kenya is fuelled due to certain factors such as the increasing prevalence of blood disorders, higher expenditure on healthcare by the government, and the rise in technological innovations leading to safer and personalized medications. The Kenya Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Roche, Novartis, Sun Pharmaceuticals, Regal Pharmaceuticals, Nextgen Pharmaceuticals, Transwide Pharmaceuticals etc, among various others.
Kenya Dental Endodontics Market Analysis
Kenya Dental Endodontics Market was valued at $1.20 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $1.80 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, development of medical tourism, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Kenya Clinical Nutrition Market Analysis
The Kenya Clinical Nutrition Market was valued at $21.5 Mn in 2023 and is projected to grow at a CAGR of 6.44% from 2023 to 2023, to $33.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nutrivea, Healthwise Kenya, Haltons Pharmacy, Mead Johnson & Company, GSK, Unilever among others.
Kenya Breast Pump Market Report
The Kenya Breast Pump Market was valued at $2.1 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $3.9 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Kenya Breast Pump Market are Amaze Surgicare, Chemco, Medela, Ameda, Avent, Evenflo, Pigeon, Playtex, Perifit, and Philips Avent, among others.
Kenya Digital Biomarkers Market Analysis
Kenya Digital Biomarkers Market was valued at $2.03 Mn in 2023 and is predicted to grow at a CAGR of 23.4% from 2023 to 2030, to $8.85 Mn by 2030. The key drivers of this industry include a focus on expanding healthcare access, the growing prevalence of chronic diseases, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Kenya Medication Access Programs Market Analysis
The Kenya Medication Access Programs Market was valued at $3.8 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $10.7 Mn by 2030. The key drivers of this industry include the rising burden of diseases, government initiatives, and technological advancements. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Kenya Cardiac Resynchronization Therapy Market
Kenya Cardiac Resynchronization Therapy Market valued at $3 Mn in 2022, projected to reach $5 Mn by 2030 with a 6.1% CAGR. The significant rise in global heart failure instances, driven by aging populations and cardiovascular conditions linked to lifestyle, emerges as a crucial catalyst propelling the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major participants in this market include Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
Kenya Biosensors Market Analysis
The Kenya Biosensors Market was valued at $20.2 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $37.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing demand for Point-of-Care (POC) testing. The prominent players of the Kenya Biosensors Market are i- SENS, SD Biosensor, Fortune Biosolutions, Glowvista Instruments, and Healthium Medtech, among others.
Kenya Cancer Induced Bone Diseases Therapeutics Market
Kenya Cancer Induced Bone Diseases Therapeutics Market valued at $1 Mn in 2022, projected to reach $2 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the rising incidence of cancer, the demographic shift to an aging population, and supportive government initiatives. The industry is primarily dominated by players such as Avenue Healthcare, AstraZeneca, Merck, Eli Lilly, Johnson & Johnson, Amgen, and Novartis among others.
Kenya Cardiac Arrhythmia Therapeutics Market
Kenya Cardiac Arrhythmia Therapeutics Market valued at $5 Mn in 2022, projected to reach $9 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the rising prevalence of cardiovascular diseases, expanding healthcare infrastructure, and evolving treatment landscape. The industry is primarily dominated by players such as Abbott, Pfizer, Metropolis, Mediheal, Chemicare, Johnson & Johnson, and Medtronic among others.
Kenya Physiotherapy Equipment Market Analysis
The Kenya Physiotherapy Equipment Market was valued at $14.63 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $25.56 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Brimstar Medical Supplies Ltd, BTL Industries, Mediquip Kenya Limited, and Enraf-Nonius BV among others.